FOXA1, observed in breast cancer [57] and HCC [58], serves as a transcriptional activator of liver-specific transcripts, stimulating AGR2 expression and fostering HCC recurrence and metastasis [59]. Here, AGR2 is linked to hepatocellular carcinoma.